Налгезин

Quick links to important sections

Налгезин

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Налгезин

Quick Facts

Property Description
Active ingredient Naproxen Sodium
Form Oral, Film-coated tablet
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common purpose Relief of pain, inflammation, and fever
Origin Synthetic (Propionic acid derivative)

What Type of Medicine is Налгезин? (Definition, Class, and Purpose)

Налгезин is a medicinal preparation whose active ingredient is Naproxen Sodium, which is clinically recognized and pharmacologically classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification identifies it as a substance effective against three key physiological responses: pain, fever, and inflammation. The preparation's foundational role is to manage generalized discomfort by providing combined analgesic, antipyretic, and anti-inflammatory effects. Naproxen Sodium chemically belongs to the propionic acid derivatives group, a family of synthetic compounds widely utilized for these systemic therapeutic effects. For instance, this type of medicine is typically employed for temporary management of mild to moderate musculoskeletal pain and associated inflammatory processes.

Naproxen Sodium: Composition and Origin

The preparation is a single active ingredient product, containing only Naproxen Sodium in its therapeutic core. It is consistently prepared in an oral dosage form, specifically as a film-coated tablet, which is designed for convenient and predictable absorption via the oral route of administration. The use of the sodium salt form, rather than the base naproxen acid, is a pharmaceutical design choice intended to optimize its solubility, leading to a relatively rapid onset of action. As a product of chemical synthesis, its origin is strictly controlled, and the tablet structure consists of the active substance integrated with pharmaceutical-grade solid excipients that form the base vehicle.

How Does Naproxen Sodium Work at a Foundational Level?

This type of medicine works by influencing the body's internal biochemical signaling pathways, primarily through a peripheral action that limits the body's generation of pain and inflammatory signals. The active substance functions by inhibiting the enzyme Cyclooxygenase (COX), thereby restricting the synthesis of prostaglandins. Prostaglandins are natural mediators that trigger the sensations of pain, inflammation, and fever. By reducing the overall availability of these mediators, Naproxen Sodium helps to control the inflammatory response at the site of discomfort, offering a direct mechanism for systemic relief that is established in pharmacology.

What side effects are possible with Налгезин?

Possible Side Effects and Safety Information

The safety profile of Naproxen Sodium, the active ingredient in Налгезин, is structured by regulatory bodies into frequency-classified adverse reactions and serious systemic risks. The majority of reactions are grouped by the affected System-Organ-Class (SOC) in official labeling.

Frequency-Classified Adverse Reactions

The adverse reactions officially classified as Common (affecting 1 to 10 users in 100) often involve the gastrointestinal and nervous systems. These frequently documented effects include dyspepsia, nausea, heartburn, abdominal pain, headache, and dizziness. Uncommon and Rare classifications account for effects such as diarrhea, visual disturbances, and more serious reactions like gastrointestinal bleeding.

Classification Examples of Effects (SOC Groupings)
Common Dyspepsia, Nausea, Headache, Dizziness, Edema
Uncommon/Rare Gastrointestinal Bleeding, Acute Renal Failure, Visual Disturbances

Serious Systemic Safety Considerations

Official regulatory documents feature prominent warnings regarding rare but clinically significant adverse events. These serious adverse reactions include the documented risk of major cardiovascular thrombotic events, such as myocardial infarction (MI) and stroke, and severe gastrointestinal events, including bleeding, ulceration, and perforation, which may occur at any time during use. Severe cutaneous adverse reactions and hypersensitivity events are also documented.

Population and Duration-Related Safety

The risk profile is subject to specific regulatory constraints for certain populations. Older adults are officially noted to be at a greater risk for serious gastrointestinal and renal adverse events. Furthermore, the risk of serious cardiovascular events may increase with the duration of use, and the medication is officially contraindicated for pain management in the setting of coronary artery bypass graft (CABG) surgery. These constraints define the limits of the medicine's documented safety profile.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Naproxen Sodium describes a range of documented signs of acute overdose. Manifestations typically include gastrointestinal issues such as nausea, vomiting, and abdominal pain, along with Central Nervous System (CNS) effects, including drowsiness, dizziness, confusion, and tinnitus.

Severe Outcomes and Emergency Action

Severe, life-threatening outcomes are officially documented and require immediate medical attention. These documented complications include major gastrointestinal bleeding, acute kidney failure (renal failure), seizures, coma, and metabolic acidosis. Since the official labeling states that no specific antidote is known for acute Naproxen Sodium toxicity, management is focused on providing symptomatic and supportive treatment.

When to Seek Urgent Help: Immediate medical attention must be sought upon suspicion of overdose or if any severe symptoms manifest. Regulatory guidance explicitly mandates calling emergency services or a local poison control center right away. Monitoring procedures, such as observation, checking vital signs, and performing an electrocardiogram (ECG), are described as necessary management steps.

Population-Specific Considerations: Official prescribing information notes that increased severity and risk of serious adverse events are documented for older adults and those with pre-existing organ impairment, such as kidney, liver, or heart conditions.

Therapeutic Uses of Налгезин

The therapeutic utility of Naproxen Sodium (Налгезин) is centered on providing symptomatic relief across major domains characterized by pain, inflammation, and fever. This medication is generally considered relevant when supportive symptom management is appropriate for conditions involving heightened physiological activity.

Relief of Musculoskeletal Pain and Inflammation

This medication is commonly applied in clinical settings involving distressing symptoms related to inflammatory or irritative states of the joints, muscles, and soft tissues. The medicine is relevant in conditions presenting with systemic or localized discomfort, and is commonly used in situations involving symptoms related to various types of arthritis (such as Osteoarthritis, Rheumatoid Arthritis, and Acute Gouty Arthritis), musculoskeletal issues like bursitis and tendinitis, and general discomfort including headaches, toothaches, and the cramping pain of Primary Dysmenorrhea.

Used in settings marked by temporary physiological imbalance, the medication may assist with easing symptoms related to localized swelling, tenderness, and stiffness. It may also provide supportive relief that helps ease the overall symptom burden when fever becomes more noticeable.

Quick Fact: Relief for Key Symptoms
Primary Focus Musculoskeletal pain, inflammatory discomfort, and fever.
Benefit Scope May assist with easing swelling, tenderness, pain, and stiffness.
Typical Context Acute flare-ups, chronic symptom management, and episodic pain.
Patient Support Can contribute to improved comfort and functional stability.

Regulatory References

  1. US National Library of Medicine MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Naproxen Sodium (Налгезин)

Eligibility Scope Official Regulatory Status
Populations for whom use is allowed Established for Adults and Adolescents aged 12 years and older. Prescription use is available for children 5 years and older for specific indications.
Populations for whom use is not recommended Use is not recommended in children under 12 for OTC use and in women attempting to conceive due to potential reversible effects on fertility.
Populations for whom use is contraindicated Patients with known hypersensitivity to naproxen, aspirin, or other NSAIDs (including aspirin-sensitive asthma). Patients with active GI ulceration or bleeding, severe heart failure, or severe renal/hepatic failure. Use is prohibited for treating pain related to Coronary Artery Bypass Graft (CABG) surgery.

Age-related eligibility rules: OTC use is not established for children under 12 years. Patients aged 60 years and older require special caution and the lowest effective dose due to increased risk of serious adverse effects.

Condition-specific eligibility rules: The medicine is contraindicated in patients with severe organ impairment. Use requires caution and monitoring in patients with moderate renal/hepatic impairment, uncontrolled hypertension, or a history of cardiovascular disease.

Pregnancy and lactation eligibility status: Use is contraindicated during the third trimester (at or after 30 weeks gestation). During the second trimester (20–29 weeks), use must be limited. Naproxen is excreted in breast milk; use is avoided unless benefits outweigh risks.


Connection to the overall eligibility profile: Regulatory documents define population eligibility through absolute contraindications for high-risk groups (e.g., severe organ failure, known hypersensitivity) and through conditional use requirements for groups like the elderly or patients with moderate organ impairment. This structure ensures that eligibility is strictly determined by the patient’s intrinsic physiological status and clinical history.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated and High-Risk Combinations

Co-administration with other Naproxen-containing products is formally prohibited as all forms circulate as the naproxen anion, significantly increasing systemic exposure and cumulative risks. Combining this medicine with Anticoagulants, SSRIs, or Corticosteroids is associated with an additive risk of serious gastrointestinal bleeding or ulceration. Similarly, use with analgesic doses of Aspirin or other NSAIDs is not generally recommended due to heightened adverse event potential.

Altered Drug Exposure and Clearance

Regulatory documents state that this medicine may cause an elevation of plasma levels for substances like Lithium and Methotrexate by reducing their clearance. Probenecid is also documented to increase naproxen plasma levels by decreasing its elimination. Conversely, Naproxen may diminish the effect of ACE-inhibitors, ARBs, and Diuretics (such as Furosemide) used for blood pressure management, and increase the risk of nephrotoxicity when combined with Ciclosporin or Tacrolimus.

Administration Constraints

Timing separation is required for Mifepristone; NSAIDs must not be administered for 8–12 days afterward to avoid reducing its efficacy. Certain Antacids or Cholestyramine may delay the absorption of the medicine. Alcohol consumption is noted to increase the risk of GI bleeding. Specific population-related warnings indicate that combining this medicine with ACE-inhibitors or ARBs in elderly, volume depleted, or renally impaired patients may result in a deterioration of kidney function.

Mechanism of Action

Core Action: Non-selective Enzyme Inhibition

The primary mechanism of Налгезин (Naproxen Sodium) involves a precise molecular interaction with the Cyclooxygenase (COX) enzymes ( COX-1 and COX-2). As a non-selective inhibitor, the drug reversibly binds to the active site of these enzymes, effectively blocking their capacity to convert Arachidonic Acid into various signaling mediators. This essential step initiates the biochemical cascade by restricting the synthesis of downstream eicosanoid mediators.

Pathway Modulation: Dampening Prostaglandin Synthesis

By restricting COX activity, the drug dramatically curtails the overall production of prostaglandins, particularly Prostaglandin E2 ( PGE2). This reduction in mediator availability correlates with a modulation of physiological responses, including a decrease in the chemical sensitization of peripheral nociceptive nerve fibers and an alteration of the elevated thermoregulatory set point within the hypothalamus. The modulation of the PGE2 pathway results in specific physiological adjustments related to the drug’s mechanistic profile.

Mechanistic Constraints

The non-selective nature of the inhibition defines the functional scope of the mechanism. The mechanism operates by affecting signaling patterns characteristic of COX-mediated events. The mechanism focuses on controlling the products of the COX cascade; it does not alter the underlying pathology or cellular processes responsible for the initial COX induction.

Dosage and Administration Information

Administration and Dosing Guidelines

Налгезин (Naproxen Sodium) is used according to established clinical practices. The primary principle governing its use is to utilize the lowest effective dose for the shortest duration necessary to achieve the desired effect.

Administration Method

  • Route of Administration: The medication is intended for Oral administration, typically as a film-coated tablet or specialized oral forms (e.g., extended-release). There are no indicated routes for injection or topical use.
  • Intake Conditions: The tablet should be swallowed whole and taken with or after food or milk to help minimize potential gastrointestinal discomfort. Specialized forms, such as enteric-coated or extended-release tablets, must not be crushed or chewed.

Standard Adult Dosing

Dosing is managed within recognized therapeutic ranges. For most conditions, the total daily dose (Naproxen Base equivalent) ranges from 500 mg to 1000 mg, usually administered once daily or twice daily (every 12 hours).

Dosing Feature Standard Guidelines
Maximum Daily Dose Generally 1000 mg to 1250 mg after the first day. Up to 1500 mg may be utilized for limited periods in severe cases.
Acute Pain Frequency After an initial loading dose (e.g., 550 mg), maintenance doses may be taken every 6 to 8 hours as needed.

Population-Specific Instructions

  • Older Adults and Impairment: A dose reduction is often considered for elderly patients and individuals with known renal or hepatic impairment, consistent with the principle of using the lowest effective dose.
  • Pediatric Use: For Juvenile Idiopathic Arthritis, the pediatric dosage is approximately 10 mg/kg of body weight per day, divided into two doses.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Налгезин

This overview outlines the structure of the clinical research for Naproxen Sodium (the active ingredient in Налгезин), detailing what has been studied, the types of outcomes monitored, and the areas where evidence remains less certain. This information describes the scientific record and does not offer clinical advice, recommendations, or predictions regarding individual outcomes.


Evidence for Use in Chronic Pain and Inflammatory Joint Conditions

This section summarizes the research structure that was evaluated in research exploring symptoms of chronic conditions like Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. Studies monitored outcomes related to physical discomfort, joint tenderness, and overall function. Regulatory reviews reported trials examining symptomatic measurements over periods of two weeks up to six months or longer. What remains uncertain is the body of long-term evidence for tracking of symptoms over time over many years, as this data is primarily based on older regulatory evaluations.

Evidence for Use in Acute Pain and Inflammation

This part details the findings from short-term clinical trials that was evaluated in research exploring acute musculoskeletal pain, including conditions like tendinitis, bursitis, and pain following procedures. The research includes single-dose, placebo-controlled RCTs. Outcomes monitored included time to onset of pain relief and total pain relief recorded over a short time window. The acute response has been monitored extensively, but the follow-up durations were limited for many trials.

Research on Acute Migraine and Headaches

This sub-section addresses the evidence from clinical trials that was evaluated in research exploring acute moderate to severe migraine attacks. Outcomes monitored included achieving patient-reported pain-free status and the change in associated symptoms. Comparative evidence is lacking in direct head-to-head trials against the full range of modern active treatments for migraine.

Research Gaps and Areas of Uncertainty

While research is available for many indications, comparative evidence is lacking for direct head-to-head trials against the full range of modern therapies. Furthermore, evidence quality varies across studies, and some older meta-analyses reported that findings were mixed or that study heterogeneity was high. Research is ongoing to define the most optimal treatment strategies, particularly concerning long-term data and comparative effectiveness against alternatives.

Key Studies & References

  1. Naproxen: MedlinePlus Drug Information (General overview and use in chronic/acute pain)
  2. Naproxen - StatPearls - NCBI Bookshelf (Overview of indications, juvenile arthritis, and headache use)
  3. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea (Cochrane Review)
  4. Naproxen in rheumatoid arthritis. A controlled trial (Example of early long-term RCT for chronic conditions)

Frequently Asked Questions (FAQ)

Common questions about Налгезин (FAQ)


Q: How quickly can I expect to feel the effect of Налгезин?

Official regulatory documents indicate that the medicine is absorbed relatively quickly. The active ingredient typically reaches its highest concentration in the bloodstream within one to two hours after taking the oral dose. This characteristic suggests a relatively prompt onset of action for pain relief, but individual responses can vary.


Q: What is the duration of action for one dose of Налгезин?

The active ingredient in Налгезин has an elimination half-life of approximately 12 to 17 hours. This long half-life means a single dose is generally associated with an extended duration of action, often requiring administration only twice daily, or approximately every 12 hours.


Q: Can people with kidney concerns generally use Налгезин?

The medicine’s eligibility profile includes a contraindication (a situation where use is not permitted) for patients who have severe renal (kidney) failure. For individuals with moderate kidney impairment, regulatory documents specify that special caution and a reduction to the lowest effective dose are required to minimize risk.


Q: Can I take Налгезин if I am taking blood pressure medication?

Regulatory information states that this medicine may diminish the blood pressure-lowering effect of common medications like ACE inhibitors, ARBs, and diuretics. Combining these drugs also increases the risk of kidney function deterioration, particularly in vulnerable patients. The need for monitoring or dose adjustments should be discussed with a qualified healthcare professional.


Q: Are there any long-term use concerns with Налгезин?

Official warnings note that the risk of serious cardiovascular thrombotic events (such as heart attack or stroke) may increase with the duration of use. For this reason, regulatory guidance specifies that the lowest effective dose should be used for the shortest duration necessary.


Q: Is Налгезин suitable for treating headache pain?

According to official OTC drug facts labels, Naproxen Sodium is indicated for the temporary relief of minor aches and pains, including those due to headache. Clinical research has also been conducted to evaluate its effectiveness for acute migraine attacks.


Q: Does taking Налгезин cause drowsiness?

While drowsiness itself may not be explicitly listed, official side effect profiles include common effects like dizziness and headache. Official information advises that activities requiring full attention, such as driving or operating machinery, should be avoided if side effects like dizziness or drowsiness occur.


Q: Can older adults typically use Налгезин?

Official regulatory documents specify that older adults face a greater risk for serious adverse events, especially related to gastrointestinal bleeding and kidney problems. Regulatory constraints specify that the lowest effective dose should be considered for use in this population.


Q: What research evidence supports the use of Налгезин for dental pain?

Official uses list the medicine for the temporary relief of pain, including that caused by a toothache. The active ingredient has also been the subject of clinical studies that explored its use for pain experienced after surgical procedures, such as dental extractions.


Q: Is it possible for Налгезин to cause allergic reactions?

Yes, official safety information documents the possibility of hypersensitivity reactions, including severe allergic reactions and severe skin reactions. The eligibility map includes a contraindication (a situation where use is not permitted) for individuals with a known allergy or severe reaction to naproxen, aspirin, or any other NSAID.


Q: What is the meaning of 'non-steroidal anti-inflammatory' in simple terms?

This term, often abbreviated as NSAID, describes a type of medicine that relieves pain (analgesic), reduces fever (antipyretic), and decreases inflammation. The 'non-steroidal' part simply means the drug is chemically distinct from steroids (corticosteroids) which also reduce inflammation.


Q: Can I use Налгезин if I am taking an antidepressant?

Regulatory documents warn that combining Naproxen with SSRIs or SNRIs (a common class of antidepressants) is associated with an additive risk of serious gastrointestinal bleeding or ulceration. Patients using this combination are advised to be carefully monitored.


Q: What are the official restrictions for using Налгезин during pregnancy?

Official regulatory guidance strictly prohibits (contraindicates) the use of this medicine from 30 weeks gestation onward (the third trimester). This restriction is in place because NSAIDs can cause premature closure of the fetal ductus arteriosus, a condition that can lead to fetal cardiac complications.


Q: Is it true that Налгезин can affect liver function?

Official product labeling includes a warning for potential hepatotoxicity, which is the possibility of liver damage. In documented cases where signs of liver disease develop or abnormal liver tests persist or worsen, the regulatory label requires the medication to be stopped.


Q: Can I take Налгезин if I have high blood pressure?

Patients with existing hypertension (high blood pressure) or a history of cardiovascular disease require caution and monitoring during use. Official information notes that this medicine may also cause new onset or worsening of existing hypertension.


Q: Is the active substance in Налгезин known to cause interactions with herbal supplements?

While specific herbal products are not individually listed on all regulatory labels, general patient guidance advises that all healthcare providers should be informed of all medicines, including herbal remedies and supplements. This ensures that any potential, undocumented interactions are considered.


Q: Is Налгезин a narcotic or addictive substance?

No. The active ingredient, Naproxen Sodium, is classified as a nonsteroidal anti-inflammatory drug (NSAID). It is not classified as a controlled substance and is not associated with chemical dependence or addiction.


Q: What are the general rules regarding driving or operating machinery while using Налгезин?

Due to the potential for adverse effects such as dizziness, drowsiness, or visual disturbances, official patient information advises caution. Official information advises that activities requiring full attention, such as driving or operating machinery, should be avoided if side effects like dizziness, drowsiness, or visual disturbances occur.


Q: Why is the use of Налгезин restricted in the later stages of pregnancy?

Use during the third trimester is restricted because NSAIDs can cause serious kidney problems in the fetus. More critically, they can cause the premature closure of the fetal ductus arteriosus, a vital fetal blood vessel, which can lead to severe heart complications.


Q: Is there any clarification on how Налгезин affects blood clotting?

Naproxen works by inhibiting the COX-1 enzyme, which is involved in platelet function. This inhibition reduces platelet aggregation, which is the technical term for blood clotting. This effect is the reason for the interaction warnings with other blood-thinning medications.


Q: What is the main difference between Налгезин and other over-the-counter pain relievers?

Налгезин contains Naproxen Sodium, which is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification means it is chemically distinct from certain other over-the-counter pain relievers and works by targeting enzymes to reduce both pain and inflammation.


Q: Is there evidence that Налгезин helps with inflammation more than just pain?

The medicine is specifically classified to provide both pain relief (analgesic) and anti-inflammatory effects. Its mechanism of action, which involves reducing mediators of both pain and inflammation, addresses both symptoms.


Q: What is the recommended period of time for continuous use of Налгезин?

For pain relief in the over-the-counter setting, use is generally limited to 10 days for pain or 3 days for fever. Use beyond these limits is defined as chronic and requires supervision.


Q: How does the listed safety profile of Налгезин compare to other NSAIDs in general terms?

Regulatory reviews have sometimes noted that naproxen may be associated with a lower risk for certain arterial thrombotic events (such as heart attack or stroke) compared to some other NSAIDs. Official guidance strictly requires using the lowest effective dose for the shortest duration necessary to mitigate all known risks.


Q: Why is the information about drug interactions so complex for Налгезин?

The complexity stems from the medicine's chemical activity, as it is highly protein-bound in the bloodstream and metabolized by certain liver enzymes. These characteristics increase the potential for interactions with other medications that share these same biological pathways.


Q: Do you need a prescription to get Налгезин in most places?

The active ingredient, Naproxen Sodium, is typically available in two forms: a lower dose (e.g., 220 mg) is approved for sale over-the-counter (OTC). Higher doses (e.g., 500 mg) usually require a prescription in most major jurisdictions.


Q: How long after taking Налгезин can I take another type of painkiller?

Because the medicine has a long half-life, its effects persist in the body for many hours. If you wish to take another class of pain reliever (such as acetaminophen), it is generally recommended to wait until the effects of the naproxen have lessened, or to seek specific timing guidance from a healthcare provider.


Q: Is Налгезин considered a strong pain reliever?

The over-the-counter dose is indicated for the temporary relief of minor aches and pains. The prescription doses are used for more serious or chronic conditions, and the medication's overall effectiveness is determined on an individual basis relative to the pain being treated.


Q: Are there common signs that the medication is starting to work?

Since the medicine is used to manage pain, inflammation, and fever, the primary sign that it is working would be a noticeable reduction in the intensity of the pain, a decrease in swelling, or a reduction in body temperature if fever is present.


Q: Does the time of day matter when taking Налгезин?

For chronic conditions requiring steady blood levels, dosing instructions often specify taking the medicine twice a day, usually morning and evening. For acute pain, the timing is less critical than ensuring that the dose is taken as needed and adheres to the maximum daily limit.


Q: Is Налгезин effective for nerve-related pain?

NSAIDs like naproxen are often included in recommendations as a first-line pharmacologic treatment for acute conditions with pain components, such as acute low back pain. However, specialized, chronic neuropathic pain typically requires a different class of medication.

How should Налгезин be stored and disposed of?

Storage and Disposal Instructions for Naproxen Sodium (Налгезин)

The official labeling for Naproxen Sodium specifies strict conditions for storage and safe disposal, based on regulatory mandates.

Storage Requirements

Naproxen Sodium tablets must be stored at controlled room temperature, specifically maintained between 20 C and 25 C (68 F and 77 F), with permitted excursions. To ensure stability, the product must be protected from light and excessive heat, and kept in its original, tightly closed container to prevent moisture exposure. A mandatory safety requirement is that the medication must be stored out of the sight and reach of children.

Disposal Requirements

Unused or expired tablets should be disposed of by utilizing a drug take-back program where available. If no take-back program is accessible, the medicine must be removed from its container, mixed with an undesirable substance (such as dirt or coffee grounds), sealed in a bag, and then discarded in the household trash according to official governmental guidance. The product should not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Налгезин found in:

A-Z Index: